| scholarly article | Q13442814 |
| P50 | author | Konstantinos E Hatzistergos | Q43204018 |
| P2093 | author name string | Bo Wang | |
| Adam Williams | |||
| Joshua M Hare | |||
| Mark A Sussman | |||
| Vasileios Karantalis | |||
| Wayne Balkan | |||
| Shathiyah Kulandavelu | |||
| Sadia Mohsin | |||
| Samuel Golpanian | |||
| Luiza Bagno | |||
| Ariel Wolf | |||
| Azorides Morales | |||
| Frederic McCall | |||
| Aaron Kupin | |||
| Aaron Rosenfeld | |||
| Julia Fritsch | |||
| Justin Grenet | |||
| Viky Y Loescher | |||
| P2860 | cites work | Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase | Q24646472 |
| Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology | Q26858965 | ||
| CADUCEUS, SCIPIO, ALCADIA: Cell therapy trials using cardiac-derived cells for patients with post myocardial infarction LV dysfunction, still evolving | Q28660773 | ||
| Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | Q29620043 | ||
| RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial | Q29620044 | ||
| Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
| Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation | Q30523741 | ||
| Rapid and sensitive detection of enhanced green fluorescent protein expression in paraffin sections by confocal laser scanning microscopy | Q30871849 | ||
| Assessment and optimization of cell engraftment after transplantation into the heart | Q33680007 | ||
| Mitochondrial integrity: preservation through Akt/Pim-1 kinase signaling in the cardiomyocyte | Q33791025 | ||
| Pim-1 kinase protects mitochondrial integrity in cardiomyocytes. | Q33828487 | ||
| c-kit+ cells minimally contribute cardiomyocytes to the heart | Q34021586 | ||
| Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. | Q34290791 | ||
| Stem cell niches in the adult mouse heart | Q34657903 | ||
| Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. | Q35004096 | ||
| Safety of intracoronary infusion of 20 million C-kit positive human cardiac stem cells in pigs | Q35532877 | ||
| Functional Effect of Pim1 Depends upon Intracellular Localization in Human Cardiac Progenitor Cells. | Q35662315 | ||
| HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia | Q36016430 | ||
| Cell-based therapy for prevention and reversal of myocardial remodeling | Q36176132 | ||
| cKit+ cardiac progenitors of neural crest origin | Q36207283 | ||
| Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy | Q36236436 | ||
| Increased mitotic rate coincident with transient telomere lengthening resulting from pim-1 overexpression in cardiac progenitor cells. | Q36342079 | ||
| Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial | Q36603453 | ||
| Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction | Q36630155 | ||
| The advancing field of cell-based therapy: insights and lessons from clinical trials. | Q37328786 | ||
| Myocardial infarction and intramyocardial injection models in swine | Q37606101 | ||
| Rejuvenation of human cardiac progenitor cells with Pim-1 kinase | Q37723749 | ||
| Pim-1 kinase inhibits pathological injury by promoting cardioprotective signaling. | Q37831454 | ||
| Swine as models in biomedical research and toxicology testing | Q37858258 | ||
| Aging and regeneration in vertebrates | Q38186825 | ||
| Cardiac MRI: a central prognostic tool in myocardial fibrosis | Q38263089 | ||
| Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. | Q38874116 | ||
| Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. | Q40907792 | ||
| Intrinsic hypoxia sensitivity of the cytomegalovirus promoter. | Q41216385 | ||
| Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. | Q42250849 | ||
| Pim-1 regulates cardiomyocyte survival downstream of Akt. | Q46022665 | ||
| Effect of exercise on left ventricular mechanical efficiency in conscious dogs | Q72893605 | ||
| Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts | Q73791469 | ||
| Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement | Q83043116 | ||
| The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction | Q84490295 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| overexpression | Q61643320 | ||
| P304 | page(s) | 2454-2464 | |
| P577 | publication date | 2016-12-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine | |
| P478 | volume | 68 |
| Q91695940 | Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues |
| Q64912607 | Age-Appropriateness of Porcine Models Used for Cell Transplantation. |
| Q89142435 | Age-Related Impaired Efficacy of Bone Marrow Cell Therapy for Myocardial Infarction Reflects a Decrease in B Lymphocytes |
| Q89433765 | Can We Engineer a Human Cardiac Patch for Therapy? |
| Q57165494 | Cardiac ageing: extrinsic and intrinsic factors in cellular renewal and senescence |
| Q64964326 | Cardiac interstitial tetraploid cells can escape replicative senescence in rodents but not large mammals. |
| Q90082403 | Cardiac regenerative therapy: Many paths to repair |
| Q47951585 | Cardiomyocyte Regeneration: A Consensus Statement |
| Q38669503 | Chasing c-Kit through the heart: Taking a broader view |
| Q39265109 | Concurrent Isolation of 3 Distinct Cardiac Stem Cell Populations From a Single Human Heart Biopsy |
| Q92447152 | Dose-dependent improvement of cardiac function in a swine model of acute myocardial infarction after intracoronary administration of allogeneic heart-derived cells |
| Q47890976 | Emerging Therapies for Congestive Heart Failure |
| Q46294258 | Empowering human cardiac progenitor cells by P2Y14 nucleotide receptor overexpression |
| Q92092817 | Enhanced cardiac repair by telomerase reverse transcriptase over-expression in human cardiac mesenchymal stromal cells |
| Q57176904 | Enhancement Strategies for Cardiac Regenerative Cell Therapy: Focus on Adult Stem Cells |
| Q57162894 | Future directions for therapeutic strategies in post-ischaemic vascularization: a position paper from European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology |
| Q88884604 | Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges |
| Q36316502 | PIM1-minicircle as a therapeutic treatment for myocardial infarction. |
| Q91787891 | Pharmacological inhibition of mTOR attenuates replicative cell senescence and improves cellular function via regulating the STAT3-PIM1 axis in human cardiac progenitor cells |
| Q88219970 | Preclinical Studies of Stem Cell Therapy for Heart Disease |
| Q57396450 | Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection Fraction |
| Q93025200 | Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells |
| Q52729630 | Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types. |
Search more.